A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
Clinical trial NCT03537157 · TERMINATED
Trial details
- NCT number
- NCT03537157
- Sponsor
- Alfasigma S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2020-07-15
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.